250 related articles for article (PubMed ID: 36916912)
1. A Single Surface-Exposed Amino Acid Determines Differential Neutralization of AAV1 and AAV6 by Human Alpha-Defensins.
Porter JM; Oswald MS; Sharma A; Emmanuel S; Kansol A; Bennett A; McKenna R; Smith JG
J Virol; 2023 Mar; 97(3):e0006023. PubMed ID: 36916912
[TBL] [Abstract][Full Text] [Related]
2. Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes.
Wu Z; Asokan A; Grieger JC; Govindasamy L; Agbandje-McKenna M; Samulski RJ
J Virol; 2006 Nov; 80(22):11393-7. PubMed ID: 16943302
[TBL] [Abstract][Full Text] [Related]
3. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.
Rutledge EA; Halbert CL; Russell DW
J Virol; 1998 Jan; 72(1):309-19. PubMed ID: 9420229
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site.
Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M
J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225
[TBL] [Abstract][Full Text] [Related]
5. Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6.
Wu Z; Miller E; Agbandje-McKenna M; Samulski RJ
J Virol; 2006 Sep; 80(18):9093-103. PubMed ID: 16940521
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.
Tseng YS; Gurda BL; Chipman P; McKenna R; Afione S; Chiorini JA; Muzyczka N; Olson NH; Baker TS; Kleinschmidt J; Agbandje-McKenna M
J Virol; 2015 Feb; 89(3):1794-808. PubMed ID: 25410874
[TBL] [Abstract][Full Text] [Related]
7. VP4 Is a Determinant of Alpha-Defensin Modulation of Rotaviral Infection.
Hu CT; Diaz K; Yang LC; Sharma A; Greenberg HB; Smith JG
J Virol; 2022 Apr; 96(7):e0205321. PubMed ID: 35285683
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo.
Palomeque J; Chemaly ER; Colosi P; Wellman JA; Zhou S; Del Monte F; Hajjar RJ
Gene Ther; 2007 Jul; 14(13):989-97. PubMed ID: 17251988
[TBL] [Abstract][Full Text] [Related]
9. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.
Woodard KT; Liang KJ; Bennett WC; Samulski RJ
J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418
[TBL] [Abstract][Full Text] [Related]
10. A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype.
Ellis BL; Hirsch ML; Barker JC; Connelly JP; Steininger RJ; Porteus MH
Virol J; 2013 Mar; 10():74. PubMed ID: 23497173
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the Serpentine Adeno-Associated Virus (SAAV) Capsid Structure: Receptor Interactions and Antigenicity.
Mietzsch M; Hull JA; Makal VE; Jimenez Ybargollin A; Yu JC; McKissock K; Bennett A; Penzes J; Lins-Austin B; Yu Q; Chipman P; Bhattacharya N; Sousa D; Strugatsky D; Tijssen P; McKenna R; Agbandje-McKenna M
J Virol; 2022 Jun; 96(11):e0033522. PubMed ID: 35532224
[TBL] [Abstract][Full Text] [Related]
12. Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.
Song L; Kauss MA; Kopin E; Chandra M; Ul-Hasan T; Miller E; Jayandharan GR; Rivers AE; Aslanidi GV; Ling C; Li B; Ma W; Li X; Andino LM; Zhong L; Tarantal AF; Yoder MC; Wong KK; Tan M; Chatterjee S; Srivastava A
Cytotherapy; 2013 Aug; 15(8):986-98. PubMed ID: 23830234
[TBL] [Abstract][Full Text] [Related]
13. Antiviral mechanisms of human defensins.
Wilson SS; Wiens ME; Smith JG
J Mol Biol; 2013 Dec; 425(24):4965-80. PubMed ID: 24095897
[TBL] [Abstract][Full Text] [Related]
14. scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution.
Öztürk BE; Johnson ME; Kleyman M; Turunç S; He J; Jabalameli S; Xi Z; Visel M; Dufour VL; Iwabe S; Pompeo Marinho LFL; Aguirre GD; Sahel JA; Schaffer DV; Pfenning AR; Flannery JG; Beltran WA; Stauffer WR; Byrne LC
Elife; 2021 Oct; 10():. PubMed ID: 34664552
[TBL] [Abstract][Full Text] [Related]
15. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
[TBL] [Abstract][Full Text] [Related]
16. Synoviocyte infection with adeno-associated virus (AAV) is neutralized by human synovial fluid from arthritis patients and depends on AAV serotype.
Boissier MC; Lemeiter D; Clavel C; Valvason C; Laroche L; Begue T; Bessis N
Hum Gene Ther; 2007 Jun; 18(6):525-35. PubMed ID: 17532727
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated Virus (AAV) Assembly-Activating Protein Is Not an Essential Requirement for Capsid Assembly of AAV Serotypes 4, 5, and 11.
Earley LF; Powers JM; Adachi K; Baumgart JT; Meyer NL; Xie Q; Chapman MS; Nakai H
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852862
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.
Boutin S; Monteilhet V; Veron P; Leborgne C; Benveniste O; Montus MF; Masurier C
Hum Gene Ther; 2010 Jun; 21(6):704-12. PubMed ID: 20095819
[TBL] [Abstract][Full Text] [Related]
19. Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies.
Li Y; Li J; Liu Y; Shi Z; Liu H; Wei Y; Yang L
Gene Ther; 2019 Jun; 26(6):264-276. PubMed ID: 31110296
[TBL] [Abstract][Full Text] [Related]
20. α-Defensin HD5 Inhibits Human Papillomavirus 16 Infection via Capsid Stabilization and Redirection to the Lysosome.
Wiens ME; Smith JG
mBio; 2017 Jan; 8(1):. PubMed ID: 28119475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
